Plain-English translation of NCT07312734 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The SEND-CF study is looking for better ways to detect lung infections in people with cystic fibrosis. Right now, doctors mainly test sputum (mucus you cough up) to find infections, but many CF patients taking newer CF medications produce less sputum, making infections harder to catch. This study collects various samples—including sputum, saliva, blood, urine, and potentially breath—to help researchers develop new diagnostic methods that can spot harmful bacteria in the lungs more reliably.
People with cystic fibrosis often develop serious lung infections that can damage their lungs over time. Although newer CF medications are helping patients, they also reduce the amount of sputum patients can produce, making it harder to diagnose infections using current methods. This trial exists to find alternative ways to detect these infections so doctors can treat them earlier and more effectively.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be asked to provide samples at study visits—this includes sputum, saliva, blood, urine, and possibly breath samples. Some participants may also take part in a sub-study involving breath samples. You'll share your health information with the research team so they can learn more about how to better detect infections in CF patients.
AI-generated summary from trial data · Jul 8, 2026 · Not medical advice
United States